Use of recombinant follicle-stimulating hormone (Gonal F) and recombinant luteinizing hormone (Luveris) for multiple follicular stimulation in patients with a suboptimal response to in vitro fertilization

Author： Lisi F.   Rinaldi L.   Fishel S.   Lisi R.   Pepe G.   Picconeri M.-G.  

Publisher： Elsevier

ISSN： 0015-0282

Source： Fertility and Sterility, Vol.79, Iss.4, 2003-04, pp. : 1037-1038

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A prospective randomized clinical trial comparing 150 IU and 225 IU of recombinant follicle-stimulating hormone (Gonal-F*) in a fixed-dose regimen for controlled ovarian stimulation in in vitro fertilization treatment

By Yong P.Y.K.   Brett S.   Baird D.T.   Thong K.J.  

Fertility and Sterility, Vol. 79, Iss. 2, 2003-02 ,pp. : 308-315

Elsevier

Access to resources Recommend Favorite

Recombinant follicle-stimulating hormone versus human menopausal gonadotropin in the late follicular phase during ovarian hyperstimulation for in vitro fertilization

By Commenges-Ducos M.   Piault S.   Papaxanthos A.   Ribes C.   Dallay D.   Commenges D.  

Fertility and Sterility, Vol. 78, Iss. 5, 2002-11 ,pp. : 1049-1054

Elsevier

Access to resources Recommend Favorite

Concentrations of inhibins and activin in women undergoing stimulation with recombinant follicle-stimulating hormone for in vitro fertilization treatment

By Casper F.W.   Seufert R.J.   Schaffrath M.   Pollow K.  

Fertility and Sterility, Vol. 75, Iss. 1, 2001-01 ,pp. : 32-37

Elsevier

Access to resources Recommend Favorite

Ovarian response and in vitro fertilization outcome in patients with reduced ovarian reserve who were stimulated with recombinant follicle-stimulating hormone or human menopausal gonadotropin

By Meo F.   Ranieri D.M.   Khadum I.   Serhal P.  

Fertility and Sterility, Vol. 77, Iss. 3, 2002-03 ,pp. : 630-632

Elsevier

Access to resources Recommend Favorite

Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon)

By de Jong D.   Macklon N.S.   Eijkemans M.J.C.   Mannaerts B.M.J.L.   Coelingh Bennink H.J.T.   Fauser B.C.J.M.   for the Ganirelix Dose-Finding Study Group  

Fertility and Sterility, Vol. 75, Iss. 4, 2001-04 ,pp. : 688-693

Elsevier

Access to resources Recommend Favorite